This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Genetic Technologies Ltd (GENE)

NASDAQ: Services

Company Balance Sheet
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Cash and Equivalents 1.79M 9.11M 5.46M 2.81M
Receivables 304.95K 507.93K 720.74K 641.36K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 2.83K 60.90K
Total Current Assets 2.47M 10.19M 6.69M 3.83M
Property, Plant & Equipment, Gross 5.04M 6.37M 6.15M 2.85M
Accumulated Depreciation & Depletion 4.65M 5.71M 5.14M 1.17M
Property, Plant & Equipment, Net 392.66K 658.41K 1.01M 1.68M
Intangibles 919.71K 1.15M 1.50M 1.26M
Other Non-Current Assets 3.65M 4.52M 0.00 0.00
Total Non-Current Assets 5.25M 6.65M 2.85M 3.21M
Liabilities & Shareholder Equity
Total Assets 7.72M 16.84M 9.54M 7.04M
Accounts Payable 927.94K 927.60K 1.19M 1.02M
Short Term Debt 0.00 18.18K 72.54K 325.19K
Other Current Liabilities 713.28K 758.24K 725.88K 600.17K
Total Current Liabilities 2.29M 1.98M 2.16M 2.11M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 89.29K 111.16K 88.42K 70.48K
Minority Interest -47.43K -9.53K -9.26K -9.72K
Total Non-Current Liabilities 201.18K 269.51K 304.31K 227.26K
Total Liabilities 2.49M 2.25M 2.47M 2.33M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 5.23M 14.59M 7.07M 4.70M
Common Par 77.70M 85.29M 77.36M 61.51M
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -76.13M -74.50M -72.10M -58.11M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 3.67M 3.81M 1.81M 1.30M
Total Capitalization 5.23M 14.59M 7.07M 4.70M
Total Equity 5.23M 14.59M 7.07M 4.70M
Total Liabilities & Stock Equity 7.72M 16.84M 9.54M 7.04M
Total Common Shares Outstanding 15.85M 15.49M 13.49M 13.49M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 15.74M 15.35M 13.49M 12.70M
Diluted Weighted Shares Outstanding 15.74M 15.35M 13.49M 12.70M
Number of Employees 64 64 58 54
Number of Part-Time Employees 0 0 0 0

GENE Genetic Technologies Ltd

Analysts Ratings for GENE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 1 1 1
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

GENE Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs